Biology:Epiblast-derived stem cell
After the blastocyst stage, once an embryo implanted in endometrium (in case of rodent), the inner cell mass (ICM) of a fertilized embryo segregates into two layers: hypoblast and epiblast. The epiblast cells are the functional progenitors of soma and germ cells which later differentiate into three layers: definitive endoderm, mesoderm and ectoderm.
Stem cells derived from epiblast are pluripotent. These cells are called epiblast-derived stem cells (EpiSCs) and have several different cellular and molecular characteristics with Embryonic Stem Cells (ESCs).[1]
Pluripotency in EpiSCs is essentially different from that of embryonic stem cells. The pluripotency of EpiSCs is primed pluripotency: primed to differentiate into specific cell lineages. Naïve pluripotent stem cells (e.g. ESC) and primed pluripotent stem cells (e.g. EpiSC) not only sustain the ability to self-renew but also maintain the capacity to differentiate.[2] Since the cell status is primed to differentiate in EpiSCs, however, one copy of the X chromosome in XX cells (female cells) in EpiSCs is silenced (XaXi). EpiSCs is unable to colonize and is not available to be used to produce chimeras. Conversely, XX cells in ESCs are both active and can produce chimera when inserted into a blastocyst.
Both ESC and EpiSC induce teratoma when injected in the test animals (scid mice) which proves pluripotency. EpiSC display several distinctive characteristics distinct from ESCs (table 1). The cellular status of human ESCs (hESCs) is similar to primed state mouse stem cells rather than naïve state.[3]
Table 1. Comparison of naïve and primed pluripotent states[2]
| Property | Naive State | Primed State |
|---|---|---|
| Embryonic tissue | Early epiblast | Egg cylinder or embryonic disc |
| Culture stem cell | Mouse ESCs | Mouse EpiSCs; primate "ESCs" |
| Blastocyst chimaeras | Yes | No |
| Teratomas | Yes | Yes |
| Pluripotency factors | Oct4, Nanog, Sox2 (high levels), Klf2, Klf4 | Oct4, Nanog, Sox2 (low levels) |
| Sox2/Oct4 dimerization | High | Low |
| Naive markers | Active Pou5f1 distal enhancer | Active Pou5f1 proximal enhancer |
| Specification markers | Absent | Fgf5, T |
| Response to Lif/Stat3 | Self-renewal | None |
| Response to Fgf/Erk | Differentiation | Self-renewal |
| Clonogenicity | High | Low |
| XX status | Both active | One X inactive |
Differentiating naïve pluripotent Stem cells into primed pluripotent stem cells (e.g. adding activin and fibroblast growth factor (FGF) in the culture medium) can be accomplished but reprogramming of primed cells into naïve cells is more difficult. Several approaches to reprogramming EpiSCs to achieve naïve pluripotency have been applied. One of those methods is overexpressing in the primed pluripotent stem cell a reprogramming factor Klf4,[4] or a cocktail of Sox2 and Klf4.[5]
The reversion back to the naive-state has also been achieved by suppressing the activity of the histone methyltransferase MLL1, also known as KMT2A. The inhibition of MLL1 via the small-molecule inhibitor MM-401 in EpiSCs showed increase in alkaline phosphatase staining as well as upregulation of "naive" markers such as Rex1 and downregulation of "primed" markers such as FGF5. Moreover, beyond the potency-state comparison, MLL1 inhibition was also shown to reactivate the silenced X-chromosome which is typically deactivated in post-implantation epiblast stem cells, suggesting an epigenetic reversion back to a more ground-level, naive state. What's more, some EpiSCs affected by the MLL1 inhibition-induced reversion were able to contribute to germline-competent chimeras, which had been considered as one of the most major differences between ESCs and EpiSCs.[6]
EpiLC
Scientists have been able to demonstrate the induction of EpiSC-like cells in vitro from mouse ESCs, which are referred to as Epiblast-like cells (EpiLC).[7] Many studies have used EpiLCs as suitable analogues for actual post-implantation derived epiblast stem cells, especially in attempts at reversion back to the "naive" state. Recently, overexpression of PR-domain Zinc Finger Protein 14 (PRDM14) in EpiLC was shown to cause a reversion back to an ESC-like state (with levels of Alkaline Phosphatase staining recovered to that observed in ESCs as well as more ESC-like cell morphology), with Klf2 being required for the mechanism to occur.[8] It has been proposed that PRDM14 induces this state by activating Klf2 via active demethylation recruitment of Oct-4; such technique has yet to be demonstrated in actual epiblast-derived EpiSCs.
References
- ↑ De-Miguel, MP (2009). "Epiblast-derived stem cells in embryonic and adult tissues.". Int J Dev Biol 53 (8–9–10): 1529–1540. doi:10.1387/ijdb.072413md. PMID 19757397. http://www.ijdb.ehu.es/web/descarga/paper/072413md.
- ↑ 2.0 2.1 Nichols, J (2009). "Naive and primed pluripotent states.". Cell Stem Cell 4 (6): 487–492. doi:10.1016/j.stem.2009.05.015. PMID 19497275.
- ↑ Hanna, J (2010). "Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs.". Proc Natl Acad Sci USA 107 (20): 9222–9227. doi:10.1073/pnas.1004584107. PMID 20442331. Bibcode: 2010PNAS..107.9222H.
- ↑ Guo, G (2009). "Klf4 reverts developmentally programmed restriction of ground state pluripotency.". Development 136 (7): 1063–1069. doi:10.1242/dev.030957. PMID 19224983.
- ↑ MacCarthy, Caitlin M.; Wu, Guangming; Malik, Vikas; Menuchin-Lasowski, Yotam; Velychko, Taras; Keshet, Gal; Fan, Rui; Bedzhov, Ivan et al. (December 2023). "Highly cooperative chimeric super-SOX induces naive pluripotency across species". Cell Stem Cell. doi:10.1016/j.stem.2023.11.010.
- ↑ "MLL1 Inhibition Reprograms Epiblast Stem Cells to Naive Pluripotency". Cell Stem Cell 18 (4): 481–94. 2016. doi:10.1016/j.stem.2016.02.004. PMID 26996599.
- ↑ "The two active X chromosomes in female ESCs block exit from the pluripotent state by modulating the ESC signaling network". Cell Stem Cell 14 (2): 203–16. 2014. doi:10.1016/j.stem.2013.11.022. PMID 24506884.
- ↑ "PRDM14 Drives OCT3/4 Recruitment via Active Demethylation in the Transition from Primed to Naive Pluripotency". Stem Cell Reports 7 (6): 1072–1086. 2016. doi:10.1016/j.stemcr.2016.10.007. PMID 27866876.
 |  |
